https://isthmus.com/news/cover-story/administrative-roadblocks-set-back-research-at-uw/

By now it’s well documented that UW-Madison lags behind most of its peers in turning its esteemed research into marketable goods. The question is what would it take for the university to get on track and become a pacesetter in the lucrative development of pharmaceutical drugs and cutting-edge medical treatment? One answer: a “major culture change spearheaded by top leadership.”

That’s the wake-up call sounded in a provocative study commissioned by UW Health and the UW School of Medicine and Public Health. Conducted by consultant Mary Westrick, who has 35 years of experience in clinical testing, the study lays out a series of stark challenges — both organizational as well as attitudinal — that threaten the campus’ declared goal to be a national leader in translating basic research into cutting-edge medical treatment....

   ...more

Ken Notes: Interesting read. I am still a fan of WARF and we get some wonderful research grants but much of our research does enter the private sector more quickly than on other campuses. The article does identify a number of private sector startups - but then suggest even our own companies are funding research at other institutions.